Oxford Nanopore Technologies cancer research media tool kit
- Home
- Oxford Nanopore Technologies cancer research media tool kit
Introduction to our work in cancer research
The genetic underpinnings of cancer are diverse and many types of genomic aberration — from SNVs to SVs, fusion transcripts, and epigenetic modifications (e.g. DNA/RNA methylation) — can fuel or signal disease. As a result, researchers have traditionally relied on multiple techniques to identify and analyse different forms of cancer.
Nanopore sequencing is disrupting that model by delivering a streamlined and rapid solution for complete characterisation of cancer samples with the potential to be deployed in handheld devices near to the sample. The technology combines many new features in DNA analysis, sequencing any length of DNA fragment, including ultra-long reads in excess of 4 Mb, spanning complex structural variants, including DNA/RNA methylation, and achieving real-time results.
Recent announcements
![Cancer cells dividing](https://a.storyblok.com/f/196663/1000x563/e856362feb/cancer-cells-dividing.jpg/m/800x0/filters:format(webp))
American Association of Cancer Research: Oxford Nanopore showcases breakthrough technology to generate most comprehensive insights into cancer genomes
![MinION Mk1B close-up](https://a.storyblok.com/f/196663/1000x563/e791eef737/minion-mk1b-open-cropped.jpg/m/800x0/filters:format(webp))
Oxford Nanopore and 4bases announce collaboration to combine nanopore sequencing devices and 4bases kits to support rapid, high-accuracy analyses in human and cancer genetics
Get in touch with our media team
Alex Doniach, Director of Corporate Communications
Contact:
alex.doniach@nanoporetech.com
Victoria Barrie, Associate Director, Strategic Communications and Corporate Affairs
Contact:
victoria.barrie@nanoporetech.com